The Effect of Arterial Pressure on the Prognosis and Survival Rate of Dialysis Patients
There have been summarized current data on the effect of various arterial pressure values on prognosis and survival rate of patients undergoing program dialysis treatment. High systolic pressure exceeding 180/90 mm Hg and low pressure — less than 110 mm Hg both before and after hemodialysis have been shown to increase the risk of cardiovascular mortality, and high pulse pressure (over 70 mm Hg) increases reliably the mortality in dialysis patients.
- Foley R.N., Parfrey P.S., Sarnak M. Epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32(Suppl 3): 12–19.
- Cohen E.P. Hypertension in chronic hemodialysis: viewing a paradox and some notes on therapy. Dial & Transplant 2000; 29: 535–542.
- Mazzuchi N., Carbonell E., Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58: 2147–2154.
- Rahman M., Sehgal A.R., Smith M.C. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257–265.
- Rocco M.V., Van G., Heyka R.J., Benz R., Cheung A.K. Risk factors for hypertension in chronic haemodialysis patients: baseline data from the НЕМО study. Am J Nephrol 2001; 21: 280–288.
- Zucchelli P. The carefull correction of renal insufficiency abnormalities: early is good. Nephrol Dial Transplant 2000; 15(Suppl 2): 2–6.
- Dorhout Mees E.J. Hypertension in haemodialysis patients: who cares? Nephrol Dial Transplant 1999; 14: 28–30.
- Dhakal M.P., Sloand J.A. Prevalence of hypertension and adequasy of blood pressure control in hemodialysis patients. Dial & Transplant 2000; 29: 628–637.
- Scribner B.H. Can antihypertensive medications control BP in haemodialysis patients: yes or no. Nephrol Dial Transplant 1999; 14: 2599–2601.
- Salem M. Hypertension in haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 1999; 14: 125–128.
- Tozawa M. et al. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi 1996; 38: 129–135.
- Zager P.G., Nikolic J. et al. ”U” curve association of blood pressure and mortality in haemodialysis patients. Kidney Int 1998; 54: 561–569.
- Port F.K., Hulbert-Sharon Т.Е., Wolfe R.A. et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507–517.
- Foley R.N., Herzog C.A., Collins A.J. Blood pressure and long-term mortality in United States haemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 2002; 62: 1784–1790.
- Klassen P.S., Lowrie E.G., Reddan D.N. et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc 2002; 287: 1548–1555.
- Zoccali C. Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 2003; 18: 249–252.
- Sytkowski P.A., Kannel W.B., D’Agnostino R.B. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. New Eng J Med 1990; 322: 1635–1641.
- Charra B., Laurent G., Calemard E., Terrat J.C. et al. Survival in dialysis and blood pressure control. Contrib Nephrol 1994; 106: 179–185.
- Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 2001; 16: 1538–1542.
- Charra B., Calemard E., Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35–44.
- Katzarski K., Charra B., Laurent G. et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369–375.
- Vaziri N.D. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1998; 33: 821–828.
- Neff M., Kim K., Persoff M. Hemodynamics of uremic anemia. Circulation 1972; 46: 456–464.
- Eschbach E.J., Abdulhadi M.H., Browne J.K. et al. Recombinant human of erythropoietin in antmic patients with end-stage renal disease: results of phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992–1000.